Diagnostic Devices Market Research & Consulting

Diagnostic devices are where a diagnosis is actually made: the endoscope that sees inside the gut, the ultrasound probe on a patient’s chest, the needle that takes a tissue sample and the sensor that reads glucose every few minutes. This page brings together the four Douglas Insights studies on those tools, each sized from procedures, installed systems and devices shipped, so hospital buyers, device makers and investors can see where diagnostic volume is growing and which technologies are taking share. The largest market covered is the Hospital Endoscopy Equipment Market, worth USD 13.6 billion in 2025 and growing 7.1% a year as screening programmes expand and single-use scopes spread. The fastest growth comes from the Continuous Glucose Monitoring Sensor Manufacturing Market, worth USD 9.05 billion and growing 9.9% a year as sensors move from insulin users to people with type 2 diabetes and over-the-counter buyers. Colour ultrasound diagnostic equipment, worth USD 5.95 billion and growing 7.3% a year, is carried by portable and point-of-care systems. The Biopsy Devices Market, worth USD 2.85 billion, follows the shift to image-guided and robotic sampling of smaller, deeper lesions found by cancer screening. Every study sets out its build receipt, regional split and scenario bands to 2035, so the numbers can be checked rather than taken on trust.